Some Parkinson's patients will be taking Tasmar (tolcapone)

March 1998

    Some Parkinson's patients will be taking Tasmar (tolcapone). It's the first drug in a new class...called COMT inhibitors.

    COMT (catechol-O-methyltransferase) is an enzyme that metabolizes levodopa to an INACTIVE metabolite. Blocking this enzyme increases the half-life of levodopa and prolongs its effect.

    Think of Tasmar as a "levodopa booster."

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote